Unknown

Dataset Information

0

Definition of fatty acid transport protein-2 (FATP2) structure facilitates identification of small molecule inhibitors for the treatment of diabetic complications.


ABSTRACT: Diabetes is a major public health problem due to morbidity and mortality associated with end organ complications. Uptake of fatty acids by Fatty Acid Transport Protein-2 (FATP2) contributes to hyperglycemia, diabetic kidney and liver disease pathogenesis. Because FATP2 structure is unknown, a homology model was constructed, validated by AlphaFold2 prediction and site-directed mutagenesis, and then used to conduct a virtual drug discovery screen. In silico similarity searches to two low-micromolar IC50 FATP2 inhibitors, followed by docking and pharmacokinetics predictions, narrowed a diverse 800,000 compound library to 23 hits. These candidates were further evaluated for inhibition of FATP2-dependent fatty acid uptake and apoptosis in cells. Two compounds demonstrated nanomolar IC50, and were further characterized by molecular dynamic simulations. The results highlight the feasibility of combining a homology model with in silico and in vitro screening, to economically identify high affinity inhibitors of FATP2, as potential treatment for diabetes and its complications.

SUBMITTER: Kumar M 

PROVIDER: S-EPMC10527240 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Definition of fatty acid transport protein-2 (FATP2) structure facilitates identification of small molecule inhibitors for the treatment of diabetic complications.

Kumar Mukesh M   Gaivin Robert J RJ   Khan Shenaz S   Fedorov Yuriy Y   Adams Drew J DJ   Zhao Weiyang W   Lee Hsueh-Yun HY   Dai Xinghong X   Dealwis Chris G CG   Schelling Jeffrey R JR  

International journal of biological macromolecules 20230610


Diabetes is a major public health problem due to morbidity and mortality associated with end organ complications. Uptake of fatty acids by Fatty Acid Transport Protein-2 (FATP2) contributes to hyperglycemia, diabetic kidney and liver disease pathogenesis. Because FATP2 structure is unknown, a homology model was constructed, validated by AlphaFold2 prediction and site-directed mutagenesis, and then used to conduct a virtual drug discovery screen. In silico similarity searches to two low-micromola  ...[more]

Similar Datasets

| S-EPMC2966498 | biostudies-literature
| S-EPMC6467689 | biostudies-literature
| S-EPMC3563081 | biostudies-literature
2024-05-13 | GSE267057 | GEO
| S-EPMC4306426 | biostudies-literature
| S-EPMC9713294 | biostudies-literature
| S-EPMC7433757 | biostudies-literature